Article info

Download PDFPDF

Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit
  1. Correspondence to:
    Professor D T Boumpas
    Department of Internal Medicine, Division of Rheumatology, Clinical Immunology and Allergy, University of Crete, Medical School, Voutes 71500, Heraklion, Greece; boumpasdmed.uoc.gr
View Full Text

Citation

Sidiropoulos P, Bertsias G, Kritikos HD, et al
Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit

Publication history

  • Accepted September 23, 2003
  • First published January 13, 2004.
Online issue publication 
January 13, 2004

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.